Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - RESEARCH & DEVELOPMENT
Research & Development ESPR - Esperion Therapeutics, Inc.
86.1 M
LAST VALUE
-9.86%
2 YEAR CAGR
-12.87%
5 YEAR CAGR
18.32%
10 YEAR CAGR